Patient Specific Predictors of Mortality in Treatment of Community Acquired Pneumonia: A Retrospective Analysis
Recommended Citation
Siddiqui S, Santana-Garces M, Zervos M, Joseph JG, Wang A. Patient Specific Predictors of Mortality in Treatment of Community Acquired Pneumonia: A Retrospective Analysis. Open Forum Infect Dis 2026; 13:S543-S544.
Document Type
Conference Proceeding
Publication Date
1-11-2026
Publication Title
Open Forum Infect Dis
Keywords
adult, age, aged, chronic kidney failure, chronic liver disease, cohort analysis, community acquired pneumonia, conference abstract, controlled study, CURB-65 score, disease severity, epidemiology, female, high risk patient, human, major clinical study, male, methicillin resistant Staphylococcus aureus, morbidity, mortality, nursing home, pneumonia, retrospective study, severity of illness index
Abstract
Background. Pneumonia is a leading cause of morbidity and mortality in hospitalized adults. Prompt identification of high-risk patients and initiation of therapy is important in improving outcomes in community acquired pneumonia (CAP). This study evaluates predictors of 30-day mortality anywhere in hospitalized CAP patients. Methods. This was a retrospective cohort study of n=10,640 hospitalized adults diagnosed with CAP between January 2022 and August 2024 at Henry Ford Hospital. Data regarding age, sex, race, nursing home residency, history of chronic kidney disease (CKD), history of chronic liver disease (CLD), history of methicillin-resistant Staphylococcus aureus (MRSA), and pneumonia severity (using CURB-65 score) was collected for each patient. Logistic regression was used to test the association between various clinical and demographic characteristics and 30-day mortality. Results. Patients with increased CURB-65 score had higher odds of death within 30 days (anywhere/in-hospital) aOR= 1.05 (95% CI 1.043-1.059, p= < 0.001). Other factors that resulted in increased odds of 30-day mortality include increasing age (OR 1.001, 95% CI 1.001-1.002, p= < 0.001) and presence of CLD (aOR 1.098, 95% CI 1.06-1.137, p=< 0.001). The adjusted odds ratio comparing odds of 30-day mortality between female and male patients was 0.985; female patients had significantly lower odds of 30-day mortality (95% CI 0.973-0.996, p=0.009). Conclusion. 30-day mortality was significantly associated with clinical factors,Including age, sex, and illness severity determined by using the CURB-65 score. These findings largely align with past literature, with the exception of female sex being associated with lower odds of death. Future work should further investigate clinical and demographic factors associated with mortality for patients with CAP.
Volume
13
First Page
S543
Last Page
S544
